American Heart Association
Cardio Diagnostics Publishes Validation Data for Molecular Coronary Heart Disease Test
The new study in the Journal of the American Heart Association shows that the firm's machine learning-based genetic-epigenetic approach can help diagnose coronary heart disease.
In future studies, the firm must show that its Lp(a)-lowering siRNA therapy lepodisiran can help patients avoid major cardiovascular events.
American Heart Association Project Aims to Fill Guidelines Gap for Lp(a) Screening, Care Management
Premium
Novartis Pharmaceuticals has backed two cardiovascular care projects studying lipoprotein(a) in the past month: one with the American Heart Association and another with 23andMe.
American Heart Association Offers Guidelines on Reporting Incidental Findings of Sequencing Tests
Any findings on "incidental variants" related to cardiovascular diseases should only be revealed to patients if they have consented to receiving the information.